Interpreting Your Results
Step-by-Step Guide
Step 1: Check Your E2 Level
| Result | Meaning |
|---|---|
| < 50 pg/mL | Too low — increase E2 dose |
| 50–100 pg/mL | Low — consider increasing |
| 100–200 pg/mL | ✅ Target range |
| 200–300 pg/mL | Acceptable (especially for monotherapy) |
| > 300 pg/mL (trough) | High — consider reducing if SHBG is elevated |
Step 2: Check Your T Level
| Result | Meaning |
|---|---|
| > 200 ng/dL | Not suppressed — increase AA or E2 |
| 100–200 ng/dL | Partially suppressed — increase AA |
| 50–100 ng/dL | Borderline — consider increase |
| < 50 ng/dL | ✅ Target range |
| < 20 ng/dL | Fully suppressed — consider reducing AA if side effects |
Step 3: Check SHBG
| Result | Meaning |
|---|---|
| 40–120 nmol/L | Normal range for trans women on HRT |
| 120–150 nmol/L | Moderate elevation — monitor |
| > 150 nmol/L | High — consider switching from oral to transdermal/injectable E2 |
Case Examples
Case 1: New Starter, Good Results
E2: 120 pg/mL ✅
T: 40 ng/dL ✅
SHBG: 55 nmol/L ✅Assessment: Great levels! Continue current regimen. Re-test in 3 months.
Case 2: E2 Too Low, T Not Suppressed
E2: 45 pg/mL ❌ Low
T: 180 ng/dL ❌ Not suppressed
SHBG: 30 nmol/L ✅Assessment: Estrogen dose is too low. Increase E2 first (e.g., from 2 mg to 4 mg oral). Re-test in 6–8 weeks.
Case 3: Good E2, T Not Suppressed
E2: 150 pg/mL ✅
T: 85 ng/dL ❌ Borderline
SHBG: 60 nmol/L ✅Assessment: E2 is fine but T needs more suppression. Increase anti-androgen (e.g., spiro 100 → 150 mg/day, or switch to CPA/bica).
Case 4: High SHBG Problem
E2: 200 pg/mL ✅
T: 30 ng/dL ✅
SHBG: 180 nmol/L ❌ HighAssessment: E2 and T look good, but SHBG is high — likely from oral estrogen. Consider switching to transdermal or injectable E2 to lower SHBG and free up more active hormones.
Case 5: Monotherapy Working
E2: 250 pg/mL ✅ (acceptable for monotherapy)
T: 25 ng/dL ✅
SHBG: 80 nmol/L ✅
Regimen: EV 6 mg every 5 days, no AAAssessment: Monotherapy is working well. Maintain current dose. No anti-androgen needed.
Case 6: High E2 but T Not Suppressed
E2: 320 pg/mL ❌ High trough
T: 70 ng/dL ❌ Not suppressed
SHBG: 140 nmol/L ⚠️ Elevated
Regimen: EV 10 mg every 5 days, no AAAssessment: Very high E2 dose with inadequate T suppression. Adding an AA (e.g., bicalutamide 25–50 mg) would be better than increasing E2 further. Also consider reducing E2 slightly.
Troubleshooting Guide
"My E2 is in range but I see no changes"
| Possible Cause | Next Step |
|---|---|
| High SHBG | Check SHBG; switch from oral to transdermal/injectable |
| Too early | HRT takes years — are you < 6 months in? |
| Genetics | Some people are slow responders |
| Low free E2 | Check free E2 (requires special test) |
| DHT still high | Add DHT test; consider finasteride if elevated |
"My T is not going down"
| Possible Cause | Next Step |
|---|---|
| AA dose too low | Increase spiro to 200 mg or switch to CPA/bica |
| E2 dose too low (for monotherapy) | Increase injectable E2 |
| Non-adherence | Are you taking meds consistently? |
| Testosterone production issue | Check LH; if suppressed, consider DHT or adrenal source |
"My prolactin is elevated"
| Level | Action |
|---|---|
| < 25 ng/mL | Normal — no action needed |
| 25–50 ng/mL | Mild elevation — monitor; recheck in 3 months |
| 50–100 ng/mL | Moderate elevation — consider switching off CPA if on it; rule out other causes |
| > 100 ng/mL | Significant elevation — stop CPA; consider pituitary MRI |
| > 200 ng/mL | High concern — likely prolactinoma; seek endocrinology consult |
Common Patterns and Solutions
| Pattern | Likely Cause | Solution |
|---|---|---|
| High E2, high SHBG, normal T | Oral estrogen | Switch to transdermal/injectable |
| Normal E2, high T | AA insufficient | Increase or switch AA |
| Normal E2, normal T, no changes | SHBG high or genetics | Check SHBG; be patient |
| High E2, normal T, no AA | Monotherapy working | Nothing — this is the goal! |
References
UCSF Transgender Care. Feminising hormone therapy. https://transcare.ucsf.edu/guidelines
Hembree WC, et al. (2017). Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons. JCEM. https://academic.oup.com/jcem/article/102/11/3869/4157558